Linking Pathophysiology to Clinical Options in Psoriasis: New Insights into Interleukin-23

This symposium includes an explanation on the autoimmune pathophysiology that underlies psoriasis, followed by a discussion on the role of the T helper 17 cell lineage and its accompanying cytokines in autoimmune diseases. The latest clinical trial data is also discussed along with how this is may change the treatment landscape of psoriasis. To conclude, a compelling question and answer session was conducted.